Functional Brands Inc (MEHA)

Functional Brands Inc. Clears Barrier to $142.9 Million BullionFX | Alchemy AcquisitionJune 3, 2026 9:07 AM
NewsfileShareholder vote satisfies a key closing conditionLake Oswego, Oregon--(Newsfile Corp. - June 3, 2026) - Functional Brands Inc. (NASDAQ: MEHA), announced that shareholders have voted to authorize the reverse stock split, removing an obstacle between the Company and the close of its $142.9 million acquisition of BullionFX | Alchemy, a gold-backed decentralized finance platform targeting retail, institutional, and blockchain markets. The Company's focus now shifts to closing the acquisition. All remaining acquisition closing conditions are actively advancing. The Company plans to provide additional, regular deal progress updates over the coming weeks. The reverse stock split ratio will be set by the Board of Directors within its authorized range prior to the effective date. The required corporate action notification will be submitted to NASDAQ pursuant to Rule 5250(e)(8).Why BullionFX | Alchemy, Why NowGold recently reclaimed its role as the world's premier hard asset, while decentralized finance infrastructure is maturing rapidly toward institutional adoption. BullionFX | Alchemy sits at that precise intersection — a gold-backed blockchain settlement layer with stablecoins, lending protocols, yield products, and Ethereum-based interoperability tools built for scale.The acquisition is structured as an all-stock transaction, meaning BullionFX becomes a direct stakeholder in the combined company's success. Every party at the table is aligned on a single outcome: building long-term value.Eric Gripentrog, Chief Executive Officer:"The shareholder vote is behind us. What's in front of us is the thing that matters — activating the Alchemy platform and closing this transaction. Our team knows what needs to happen and is executing, and looks forward to providing additional updates in the coming weeks. "About Functional Brands Inc.
Functional Brands Inc. (NASDAQ: MEHA) is a leading innovator in wellness and performance products dedicated to Making Everyone Healthy Again™. The Company's portfolio includes Kirkman®, one of the most trusted names in nutritional supplements for over 75 years with products available in more than 35 countries; P2i™ by Kirkman® Prenatal Multivitamin & Multimineral, the first prenatal supplement to align with FIGO standards and comply with California SB 646; and Tru2u.health, a consumer-facing telehealth and wellness platform. Functional Brands operates an FDA-registered, cGMP-compliant manufacturing facility in Oregon. For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health Investor Relations Contact:
FunctionalBrands@icrinc.comCautionary Note Regarding Forward-Looking StatementsThis news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, the ability of the parties to negotiate final terms of a definitive acquisition agreement, the closing of the contemplated asset purchase agreement, including expected conditions to closing which are anticipated to include regulatory approvals, valuations, and future shareholder approvals; the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the Company or BullionFX (collectively, the "Parties") to terminate the asset purchase agreement; the effect of such termination; the outcome of any legal proceedings that may be instituted against Parties or their respective directors or officers; the ability to obtain regulatory and other approvals and meet other closing conditions for the asset acquisition on a timely basis or at all, including the risk that any regulatory and other approvals required may not obtained on a timely basis or at all, or are obtained subject to conditions that are not anticipated or that could adversely affect the combined company or the expected benefits of the transaction; difficulties and delays in integrating BullionFX's assets in the Company; prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting the parties; potential adverse reactions or changes to business relationships resulting from the announcement of the expected acquisition; uncertainty as to the long-term value of the common stock of the Company following the acquisition; the significant dilution to the Company's stockholder in connection with the acquisition; the continued availability of capital and financing following the potential acquisition transaction; the business, economic and political conditions in the markets in which the Parties operate; and the fact that the Company's reported earnings and financial position may be adversely affected by tax and other factors.Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands' Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299951 Original: Functional Brands Inc. Clears Barrier to $142.9 Million BullionFX | Alchemy Acquisition

The deal should be locked within a few days, not months

I see 👀  so we're looking at what 5 to 6 months b4 this deal fully completes?
Enough time to load up

Reverse merger with $143m defi gold vehicle

What's this special meeting about?
Hopefully no RS? Right?

What's the big catalyst here?

Functional Brands Announces Adjournment of Special Meeting of StockholdersMay 27, 2026 7:00 PM
NewsfileScheduled to Reconvene on June 1, 2026Lake Oswego, Oregon--(Newsfile Corp. - May 27, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that the Company's Special Meeting of Stockholders (the "Special Meeting") scheduled to be held on May 28, 2026 at 1:00 p.m. Eastern Time has been adjourned to Monday, June 1, 2026 at 10:00 a.m. Eastern Time. The meeting is being conducted virtually via webcast. No changes have been made to the proposals to be voted on by stockholders at the Special Meeting. The Company's proxy statement and any other materials filed by the Company with the SEC can be obtained free of charge at the SEC's website at www.sec.gov.The record date for the adjourned Special Meeting continues to be April 16, 2026. No action is required by any stockholder who has previously delivered a proxy and who does not wish to revoke or change that proxy.The Company strongly encourages any eligible stockholder that has not yet voted their shares, or provided voting instructions to their broker or other record holder, to do so promptly. For questions relating to the voting of shares or to request additional or misplaced proxy voting materials, please contact the Company's proxy solicitor: Lioness Consulting LLC at 1-877-672-7073.About Functional Brands Inc.
Functional Brands Inc. (NASDAQ: MEHA) is a leading innovator in wellness and performance products dedicated to Making Everyone Healthy Again™. The Company's portfolio includes Kirkman®, one of the most trusted names in nutritional supplements for over 75 years with products available in more than 35 countries; P2i™ by Kirkman® Prenatal Multivitamin & Multimineral, the first prenatal supplement to align with FIGO standards and comply with California SB 646; and Tru2u.health, a consumer-facing telehealth and wellness platform. Functional Brands operates an FDA-registered, cGMP-compliant manufacturing facility in Oregon. For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health Investor Relations Contact:
FunctionalBrands@icrinc.comCautionary Note Regarding Forward-Looking StatementsThis news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, the ability of the parties to negotiate final terms of a definitive acquisition agreement, the closing of the contemplated asset purchase agreement, including expected conditions to closing which are anticipated to include regulatory approvals, valuations, and future shareholder approvals; the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the Company or BullionFX (collectively, the "LOI Parties") to terminate the LOI agreement; the effect of such termination; the outcome of any legal proceedings that may be instituted against LOI Parties or their respective directors or officers; the ability to obtain regulatory and other approvals and meet other closing conditions for the asset acquisition on a timely basis or at all, including the risk that any regulatory and other approvals required may not obtained on a timely basis or at all, or are obtained subject to conditions that are not anticipated or that could adversely affect the combined company or the expected benefits of the transaction; the ability to obtain any necessary approval by the Company's stockholders on the expected schedule of the transactions contemplated by the LOI; difficulties and delays in integrating BullionFX's assets in the Company; prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting the parties; potential adverse reactions or changes to business relationships resulting from the announcement of the LOI and future expected acquisition; uncertainty as to the long-term value of the common stock of the Company following the acquisition; the significant dilution to the Company's stockholder in connection with the acquisition; the continued availability of capital and financing following the potential acquisition transaction; the business, economic and political conditions in the markets in which the LOI Parties operate; and the fact that the Company's reported earnings and financial position may be adversely affected by tax and other factors.Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands' Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299155 Original: Functional Brands Announces Adjournment of Special Meeting of Stockholders

Fluff news.

Nice news!!

Functional Brands Enters into Agreement to Acquire Alchemy, a Gold-Backed Blockchain Settlement Platform, in a $142.9 Million TransactionMay 22, 2026 9:00 AM
NewsfileDefinitive agreement signed; management communicates rationale targeting activation in Q3 2026; gold-backed DeFi platform designed to deliver above-market yield on physical gold positions - compared to near 0% for traditional gold ETFs.Lake Oswego, Oregon--(Newsfile Corp. - May 22, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("Functional Brands" or the "Company") today announced the execution of a definitive agreement for the acquisition of assets from BullionFX, including its Alchemy technology platform; a vertically integrated, gold-backed blockchain settlement layer and decentralized finance (DeFi) ecosystem targeting retail, institutional, and blockchain markets (the "Acquired Assets"). The transaction is valued at $142.9 million in an all-stock asset acquisition and has been unanimously approved by the boards of directors of both companies. Management views the platform as differentiated from existing tokenized-gold products by the depth and integration of its technology stack (more information available at www.alchemy.xyz)."Gold is having a generational moment, and we expect the acquisition of the Alchemy technology suite will give us the infrastructure to be at the center of it. A full-stack, gold-backed DeFi platform that no publicly listed company currently owns. We're excited to close this transaction and commercialize the plan," said Eric Gripentrog, CEO Functional Brands."We are excited to bring the Alchemy ecosystem to Retail, Institutional, and Blockchain markets. We are quickly moving into an era where bridged traditional and decentralized financial products, along with user self-custody, trustless systems, and stability are set to revolutionize the financial industry as we know it," said Stephen Moss, Founder BullionFX | Alchemy.Transaction SummaryThe transaction is an all-stock asset acquisition valued at $142.9 million, unanimously approved by the boards of both Functional Brands and BullionFX. Closing remains subject to conditions including, but not limited to, due diligence, regulatory approvals, and a valuation. Following the binding LOI dated May 11, 2026, both parties executed the definitive agreements on May 22, 2026.The Market OpportunityGold reached all-time highs in 2025, driven by central-bank purchasing, geopolitical tension, and growing demand for non-sovereign stores of value. Yet existing tokenized-gold products remain functionally limited — price exposure with no yield, no programmability, and no ecosystem. Alchemy's decentralized ecosystem is built on the stability of gold, providing stable backing to various products, including USD deposits, and has been designed to disrupt three core markets:Retail. Self-custody and stablecoins have given users sovereignty and price stability, but existing blockchain products fall short of the everyday utility needed for a stablecoin to function as real money. Alchemy delivers that missing layer: a decentralized platform built around USD and gold, combining stability with the practical functionality required for payments, yield, DeFi, and broader ecosystem use.Institutional. Bridging traditional and decentralized financial products opens the door to a new class of "fused" instruments — combining low-cost debt with high offsets and yields to outperform legacy markets. Alchemy has built a suite of market-leading yield engines that generate above-market returns on USD and gold, making MEHA extremely well positioned to be able to activate a pipeline of institutional applications: above-market-yielding exchange-listed USD and gold funds, yield-bearing loan offsets, and products that remove counterparty bank risk by holding USD exposure as physically-backed, hedged gold.Blockchain. Blockchain markets are inherently volatile and unstable, which has capped what can be built on them. Alchemy changes the substrate: a Layer 2 secured by Ethereum and denominated in gold, giving developers a stable foundation for the next generation of financial and non-financial applications.Strategic Rationale & Go-Forward ConsolidationManagement believes that, as a Nasdaq-listed operating company with established public-market disclosure and governance infrastructure, the Company is well-positioned to serve as a consolidation vehicle in the tokenized real-world-asset and gold-anchored DeFi segments. The Company's listed stock provides a recognized acquisition currency for evaluating complementary technology and protocol opportunities as the sector matures.About Functional Brands Inc.Functional Brands Inc. (NASDAQ: MEHA) is focused on becoming a diversified operating company with two business lines: an established wellness and performance products division and a newly acquired gold-backed DeFi technology platform. The Company's wellness portfolio includes Kirkman®, one of the most trusted names in nutritional supplements for over 75 years with products available in more than 35 countries; P2i™ by Kirkman® Prenatal Multivitamin & Multimineral, the first prenatal supplement to align with FIGO standards and comply with California SB 646; and Tru2u.health, a consumer-facing telehealth and wellness platform. Functional Brands operates an FDA-registered, cGMP-compliant manufacturing facility in Oregon. For more information, visit www.functionalbrandsinc.com, www.kirkmangroup.com, or www.tru2u.health.Investor Relations Contact: FunctionalBrands@icrinc.comCautionary Note Regarding Forward-Looking StatementsThis news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements related to the closing of the asset acquisition, including the satisfaction of closing conditions, the timing associated therewith and dilution caused thereby, the anticipated benefits of the acquisition, the commercialization plan and its phases and timing, projected commercialization costs, the construction and deployment of an on-balance-sheet treasury, the potential establishment or listing of one or more Stable Asset Treasury vehicles, the design-stage yield estimates described herein, the development of any TradFi Fusion Product concepts, and the Company's longer-term consolidation rationale. Forward-looking statements often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "targets," "will," "should," "could," "would," "may," and similar words. These statements are based on information available as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events, or results.Important factors that may cause actual results to differ materially include: the ability of the parties to satisfy the conditions to closing; the occurrence of any event giving rise to termination of the asset purchase agreement; the outcome of any legal proceedings; the ability to obtain regulatory and other approvals on a timely basis or at all; difficulties and delays in transferring, integrating, and commercializing the Acquired Assets; the cost, timing, and capital requirements of the commercialization plan; the volatility of digital-asset markets and the price of gold; the evolving regulatory environment for tokenized real-world assets, stablecoins, DeFi protocols, treasury vehicles, and consumer digital-asset applications in the United States and globally; cybersecurity, smart-contract, and operational risks inherent in blockchain-based products; the Company's ability to obtain additional capital on favorable terms or at all; the dilutive effect on existing stockholders of the preferred shares issued as part of the acquisition, and the conversion thereof, and any subsequent financings; the concentration of consideration share ownership; uncertainty as to the long-term value of the Company's common stock; the Company's going concern status and dependence on future capital raises; NASDAQ listing compliance requirements and bid price maintenance; and tax and other factors.This release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. Readers are cautioned not to place undue reliance on forward-looking statements, which apply only as of the date of this news release. Investors should review Functional Brands' filings with the SEC, including the Registration Statement on Form S-1 filed October 16, 2025, and the Annual Report on Form 10-K filed March 27, 2026, available at www.sec.gov. The Company does not undertake to update forward-looking statements except as required by law.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298553 Original: Functional Brands Enters into Agreement to Acquire Alchemy, a Gold-Backed Blockchain Settlement Platform, in a $142.9 Million Transaction

MEHA....................p/m

Heavy volume with a nice spike this morning....glta 

MEHA.........................https://stockcharts.com/sc3/ui/?s=MEHA&p=W&b=5&g=0&id=p86431144783

Functional Brands Announces First Quarter 2026 Financial ResultsMay 18, 2026 8:00 AM
NewsfileLake Oswego, Oregon--(Newsfile Corp. - May 18, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the first quarter ended March 31, 2026.First Quarter 2026 Financial HighlightsRevenue grew to $1.65 million, up 3.5% from $1.59 million in the prior year period, reflecting continued momentum across the Company's brand portfolio.Gross profit increased to $0.96 million from $0.87 million in the prior year period and gross margin increased 390 basis points to 58.4%, driven by continued focus on higher margin channels.Operating loss increased to $0.68 million from $0.03 million in the prior year period, largely reflecting expenses related to becoming a public company.Net loss of $7.0 million reflected a $6.3 million of non-cash GAAP charge on equity exchange. Strategic HighlightsContinued expansion of Kirkman® distribution across eCommerce, retail, and international channels.Tru2u.health platform gaining traction with growing registered user base.P2i™ Prenatal line achieving broader practitioner and retail placement following iHerb listing.Strategic AI partnership with partnrup.ai driving qualified traffic acquisition for Tru2u.health.Entered into a binding letter of intent regarding the acquisition of intellectual property and related blockchain-based assets. Completed a capital structure simplification."Our recent results reflect important strategic and operational progress, including revenue growth, a 390 basis point expansion of gross margin, and the completion of a simplification of our capital structure," said Eric Gripentrog, CEO of Functional Brands Inc. "Over the past several months, we've executed a series of key initiatives that mark a pivotal period in the Company's evolution and establish a strong foundation for sustainable, profitable growth."Financial Results for the Quarter Ended March 31, 2026: RevenueNet revenue for the three months ended March 31, 2026 was $1,645,524 compared to $1,590,256 for the three months ended March 31, 2025 representing an increase of approximately 3.5%. This increase of $55,268 in net revenue was primarily due to the increase in the demand from our direct-to-consumer sales channel.Gross profitGross profit for the three months ended March 31, 2026 was $961,133 compared to 866,764 representing an increase of 11%. This increase of $94,369 was primarily due to the increase in demand from direct-to-consumer sales channel and operational efficiencies. Gross profit margin increased 390 basis points to 58.4%, driven by continued focus on higher margin channels.Sales and marketing expensesSales and marketing expenses for the three months ended March 31, 2026, was $263,707 compared to $178,630 for the three months ended March 31, 2025, representing an increase of approximately 48%. This increase of $85,077 was primarily due to the increase in amazon referral fees and commissions moving from a wholesaler model to a Direct Seller's Central model.General and administrative expensesGeneral and administrative expenses for the three months ended March 31, 2026 was $1,380,231, compared to $720,234 for the three months ended March 31, 2025, representing an increase of approximately 92%. This increase of $659,997 was primarily attributable to an increase professional fees and payroll.Other income / (expenses)Other income /expense for the three months ended March 31, 2026 was a negative $6,307,984 compared to a negative of $94,682 for the three months ended March 31, 2025. This increase of $6,213,302 was primarily due to the loss on issuance of preferred stock of $6,310,464, a reduction in interest expense of $69,290, and a change of fair value of derivative liability of $25,374.About Functional Brands Inc.
Functional Brands Inc. (NASDAQ: MEHA) is a leading innovator in wellness and performance products dedicated to Making Everyone Healthy Again™. The Company's portfolio includes Kirkman®, one of the most trusted names in nutritional supplements for over 75 years with products available in more than 35 countries; P2i™ by Kirkman® Prenatal Multivitamin & Multimineral, the first prenatal supplement to align with FIGO standards and comply with California SB 646; and Tru2u.health, a consumer-facing telehealth and wellness platform. Functional Brands operates an FDA-registered, cGMP-compliant manufacturing facility in Oregon.For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health.Investor Relations Contact:FunctionalBrands@icrinc.comCautionary Note Regarding Forward-Looking StatementsThis news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, the ability of the parties to negotiate final terms of a definitive acquisition agreement, the closing of the contemplated asset purchase agreement, including expected conditions to closing which are anticipated to include regulatory approvals, valuations, and future shareholder approvals; the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the Company or BullionFX (collectively, the "LOI Parties") to terminate the LOI agreement; the effect of such termination; the outcome of any legal proceedings that may be instituted against LOI Parties or their respective directors or officers; the ability to obtain regulatory and other approvals and meet other closing conditions for the asset acquisition on a timely basis or at all, including the risk that any regulatory and other approvals required may not obtained on a timely basis or at all, or are obtained subject to conditions that are not anticipated or that could adversely affect the combined company or the expected benefits of the transaction; the ability to obtain any necessary approval by the Company's stockholders on the expected schedule of the transactions contemplated by the LOI; difficulties and delays in integrating BullionFX's assets in the Company; prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting the parties; potential adverse reactions or changes to business relationships resulting from the announcement of the LOI and future expected acquisition; uncertainty as to the long-term value of the common stock of the Company following the acquisition; the significant dilution to the Company's stockholder in connection with the acquisition; the continued availability of capital and financing following the potential acquisition transaction; the business, economic and political conditions in the markets in which the LOI Parties operate; and the fact that the Company's reported earnings and financial position may be adversely affected by tax and other factors.Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands' Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.FUNCTIONAL BRANDS INC.
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In U.S. dollars, except share data or otherwise noted)
March 31, December 31,
2026 2025Assets

 

Current assets:

 

Cash$1,077,967
 $2,726,696
Accounts receivable, net
372,712
 
518,474
Inventories, net
1,591,548
 
1,549,511
Prepaid expenses and other current assets
355,096
 
392,999
Total current assets
3,397,323
 
5,187,680
Noncurrent assets:
 
 
 
Property and equipment, net
32,797
 
37,379
Right-of-use assets, net
1,579,814
 
1,667,693
Intangible assets, net
1,385,879
 
1,397,411
Goodwill
818,139
 
818,139
Total non-current assets
3,816,629
 
3,920,622
Total assets$7,213,952
 $9,108,302
  
 
 
 
Liabilities and stockholders' equity / (deficit)
 
 
 
Current liabilities:
 
 
 
Accounts payable and accrued liabilities$1,645,659
 $1,554,243
Line of credit
-
 
8,109
SBA loan, current
3,614
 
3,595
Lease liabilities, current
375,479
 
371,272
Other current liabilities
30,678
 
41,828
Derivative liabilities, current
-
 
3,306,745
Liability with conditional timing
450,000
 
-
Loans payable (related party), current
64,527
 
61,642
Loans payable
267,883
 
402,650
Total current liabilities
2,837,840
 
5,750,084
Non-current liabilities:
 
 
 
Lease liabilities, net of current
1,340,313
 
1,435,505
SBA loan, net of current
135,957
 
136,873
Convertible note
837,800
 
-
Derivative liabilities, noncurrent
313,392
 
-
Preferred shares liabilities
6,032,160
 
-
Loan payable (related party), net of current
227,254
 
244,509
Total non-current liabilities
8,886,876
 
1,816,887
  
 
 
 
Total liabilities
11,724,716
 
7,566,971
  
 
 
 
Stockholders' equity / (deficit)
 
 
 
Series A Preferred stock, par value $0.001 stated value $100, 100,000 shares authorized in 2026 and 2025; 0 and 87,445 shares issued and outstanding, respectively
-
 
87
Series B Preferred stock, par value $0.001 stated value $100, 80,000 authorized in 2026 and 2025; 2,400 and 28,475 shares issued and outstanding, respectively
2
 
28
Series C Preferred stock, par value $0.001 stated value $1,000, 6,100 and 0 authorized in 2026 and 2025; 6,032 and 0 shares issued and outstanding, respectively
-
 
-
Common stock, $0.00001 par value, 220,000,000 shares authorized, 21,354,686 and 18,704,649 shares outstanding, and 5,190,171 and 0 shares to be issued respectively.
267
 
187
Additional paid-in capital
9,538,131
 
8,522,354
Accumulated deficit
(14,049,164) 
(6,981,325)Total stockholders' equity / (deficit)
(4,510,764) 
1,541,331
Total liabilities and stockholders' equity / (deficit)$7,213,952
 $9,108,302
 The accompanying notes are an integral part of these unaudited consolidated financial statements.FUNCTIONAL BRANDS INC.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In U.S. dollars, except share data or otherwise noted)
Three
Months
Ended Three
Months
Ended
March 31, March 31,
2026 2025Revenue, net of returns
1,645,524
 
1,590,256
Cost of goods sold
684,391
 
723,492
Gross profit
961,133
 
866,764
Operating expenses
 
 
 
Sales and marketing
263,707
 
178,630
General and administrative
1,380,231
 
720,234
Total operating expenses
1,643,938
 
898,864
Operating loss
(682,805) 
(32,100)Other income / (expense)
 
 
 
Interest income
2,910
 
299
Other income
-
 
113
Interest expense
(25,804) 
(95,094)Change in fair value of derivative liabilities
25,374
 
-
Loss on issuance of preferred stock
(6,310,464) 
-
Total other income / (expense)
(6,307,984) 
(94,682)Net loss$(6,990,789) $(126,782)Net loss per share of common stock attributable to common stockholders
-
 
 
Basic$(0.36) $(0.02)Diluted$(0.36) $(0.02)Weighted average shares used in computing net loss per share of common stock
 
 
 
Basic
19,594,102
 
6,917,226
Diluted
19,594,102
 
6,917,226
 The accompanying notes are an integral part of these unaudited consolidated financial statements.FUNCTIONAL BRANDS INC.
CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED)
(In U.S. dollars, except share data or otherwise noted)
Three
Months
Ended Three
Months
Ended
March 31, March 31,
2026 2025Cash flows from operating activities:

 

Net loss$(6,990,789) $(126,782)Reconcile net loss to cash provided by operating activities
 
 
 
Allowance for doubtful accounts receivable
-
 
(1,968)Allowance for inventory obsolescence
-
 
18,464
Depreciation of property and equipment
4,582
 
6,225
Amortization of right-of-use assets
87,879
 
80,355
Amortization of intangible assets
11,532
 
11,532
Stock-based compensation
123,288
 
252,905
Financing expense on warrants
-
 
23,138
Change in fair value of derivative liabilities
(25,374) 
-
Loss on issuance of preferred stock
6,310,464
 
-
Dividends
(77,050) 
-
Changes in operating assets and liabilities:
 
 
 
Accounts receivable
145,762
 
5,841
Inventories
(42,037) 
(111,142)Prepaid expenses and other current assets
37,903
 
17,029
Accounts payable and accrued liabilities
91,416
 
86,959
Other current liabilities
(11,150) 
(7,065)Lease liabilities
(90,985) 
(79,498)Net cash provided by (used in) operating activities
(424,559) 
175,993
  
 
 
 
Cash flows from investing activities:
 
 
 
Net cash used in investing activities:
-
 
-
  
 
 
 
Cash flows from financing activities:
 
 
 
Deferred offering costs
-
 
(127,775)Payments for payable for acquisition
-
 
(44,999)Repayment of liability conditional timing
(450,000) 
-
Repayment of loans
(149,137) 
(1,685)Buyback of preferred stock
(616,027) 
-
Proceeds from line of credit
-
 
48,947
Line of credit repayment
(8,109) 
(47,598)SBA loan repayment
(897) 
(894)Net cash used in financing activities
(1,224,170) 
(174,004)  
 
 
 
Increase (decrease) in cash
(1,648,729) 
1,989
  
 
 
 
Cash beginning of period
2,726,696
 
211,642
   
 
 
 
Cash, end of period$1,077,967
 $213,631
  
 
 
 
Supplemental disclosures of cash flow information
 
 
 
Cash paid for interest$19,469
 $71,980
Non-cash investing and financing activities
 
 
 
Declaration of preferred stock dividend recorded as an increase in accrued liabilities
77,050
 
-
  
 
 
 
Extinguishment of Series A&B preferred shares$(97) 
 
Derecognition of derivative liabilities upon extinguishment of Series A&B preferred shares$(3,027,287) 
 
Issuance of Series C preferred shares$(6,032,160) 
 
Recognition of Series C convertible notes$(837,000) 
 
Recognition of derivative liabilities upon issuance of Series C preferred shares & convertible notes$(529,854) 
 
 The accompanying notes are an integral part of these unaudited consolidated financial statements.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297768 Original: Functional Brands Announces First Quarter 2026 Financial Results

It appears that MEHA might provide shareholders a fun day.

https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=MEHA

Functional Brands Inc. Announces Conversion Price Adjustment Agreement for Series C Preferred StockMay 12, 2026 8:00 AM
NewsfileLake Oswego, Oregon--(Newsfile Corp. - May 12, 2026) - Functional Brands Inc. (NASDAQ: MEHA), (the "Company"), a leading innovator in wellness and performance products, today announced that it has entered into a Conversion Price Reduction and Waiver Agreement with all holders of the Company's Series C Convertible Preferred Stock.Under the terms of the Agreement, the conversion price applicable to the Series C Preferred Stock during the Fixed Conversion Period has been modified to $0.1636 per share of common stock, reflecting the current market price at the time of execution. This new conversion price replaces the existing tiered conversion prices and related tier allocation structure. The Company and the holders have also mutually waived the prohibition on below-price conversions with respect to conversions at the reduced conversion price. "This agreement demonstrates our commitment to fostering alignment among all of our stockholders while maintaining capital structure flexibility," said Eric Gripentrog, CEO of Functional Brands Inc. "By resetting the Series C conversion price to reflect current market realities, we're eliminating a structural overhang that has weighed on our common stock while simultaneously providing our preferred holders with a more practical path to liquidity. This balanced approach removes uncertainty, strengthens our financial position, and allows management to focus on executing our growth strategy to drive long-term value."About Functional Brands Inc. (NASDAQ: MEHA)Functional Brands Inc. (NASDAQ: MEHA) is a health and wellness company dedicated to delivering innovative, evidence-based therapeutic solutions through its proprietary digital platform, Tru2u.health. The Company's mission is to make clinically meaningful health optimization accessible, personalized, and scalable for every member. Functional Brands develops and distributes a curated portfolio of functional health products, peptide therapies, and telehealth services designed to support metabolic health, longevity, and overall wellbeing.Contacts: FunctionalBrands@icrinc.comCautionary Note Regarding Forward-Looking StatementsThis news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, the ability of the parties to negotiate final terms of a definitive acquisition agreement, the closing of the contemplated asset purchase agreement, including expected conditions to closing which are anticipated to include regulatory approvals, valuations, and future shareholder approvals; the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the Company or BullionFX (collectively, the "LOI Parties") to terminate the LOI agreement; the effect of such termination; the outcome of any legal proceedings that may be instituted against LOI Parties or their respective directors or officers; the ability to obtain regulatory and other approvals and meet other closing conditions for the asset acquisition on a timely basis or at all, including the risk that any regulatory and other approvals required may not obtained on a timely basis or at all, or are obtained subject to conditions that are not anticipated or that could adversely affect the combined company or the expected benefits of the transaction; the ability to obtain any necessary approval by the Company's stockholders on the expected schedule of the transactions contemplated by the LOI; difficulties and delays in integrating BullionFX's assets in the Company; prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting the parties; potential adverse reactions or changes to business relationships resulting from the announcement of the LOI and future expected acquisition; uncertainty as to the long-term value of the common stock of the Company following the acquisition; the significant dilution to the Company's stockholder in connection with the acquisition; the continued availability of capital and financing following the potential acquisition transaction; the business, economic and political conditions in the markets in which the LOI Parties operate; and the fact that the Company's reported earnings and financial position may be adversely affected by tax and other factors.Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands' Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.# # #To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297088 Original: Functional Brands Inc. Announces Conversion Price Adjustment Agreement for Series C Preferred Stock

wow, 900M+ traded so far. It's going to go up from here. It can trigger upward anytime soon.

.159 is now.

That would mean issuing another 800 million shares.Then probably a RS to follow,this will be short lived.Good luck and good trading.

Gold-Backed DeFi Acquisition Could Transform Functional Brands (MEHA) Into Blockchain Finance PlayerMay 11, 2026 10:54 AM
IH Market News Functional Brands is moving beyond wellness products with a proposed $142.9 million BullionFX asset acquisition tied to gold-backed stablecoins, decentralized finance infrastructure, and blockchain-based payment systems. Key Investor Takeaways Functional Brands Inc. (NASDAQ:MEHA) signed a binding LOI to acquire BullionFX and its Alchemy platform in a $142.9 million all-stock transaction. The gold-backed DeFi acquisition would shift MEHA into blockchain finance and digital asset infrastructure tied to physical gold reserves. BullionFX technology includes stablecoins, lending protocols, yield products, and Ethereum-based interoperability tools. The transaction could expand MEHA’s long-term growth narrative beyond wellness and telehealth into decentralized financial services. Investors may focus on execution risks, regulatory review, and whether the company can commercialize the proposed gold-backed ecosystem. Why (NASDAQ:MEHA) Stock Is in Focus Functional Brands announced a binding Letter of Intent to acquire the assets of BullionFX, including its Alchemy platform, in an all-stock deal valued at approximately $142.9 million.The acquisition is designed to give the company access to blockchain infrastructure, intellectual property, and decentralized finance technology built around auditable physical gold reserves.According to the company, the BullionFX assets support a broader ecosystem that includes gold- and USD-backed stablecoins, decentralized lending and borrowing tools, yield-generating products, and cross-chain interoperability features.The platform is also designed to integrate with traditional financial systems while operating on blockchain networks including Ethereum.CEO Eric Gripentrog described the transaction as transformational, stating: “The BullionFX Assets are expected to enable us to create what we believe is the most credible bridge between physical gold markets and decentralized finance.”BullionFX creator Stephen Moss said the platform is intended to support institutional-grade products, including gold-denominated exchange-traded funds and a USD stablecoin backed by physical gold.The proposed transaction remains subject to due diligence, regulatory review, board approvals, and final definitive agreements. Why This Matters for Investors The announcement materially changes the narrative around Functional Brands.The company currently operates as a health and wellness business focused on telehealth and therapeutic products, but the BullionFX acquisition would introduce exposure to digital assets, decentralized finance infrastructure, and tokenized real-world assets.That shift may attract speculative interest from traders focused on blockchain and fintech themes, particularly because the transaction centers on gold-backed digital finance rather than traditional cryptocurrencies alone.The proposed ecosystem also attempts to address a key issue within decentralized finance: collateral credibility. By anchoring products to audited physical gold reserves, the platform could position itself differently from purely fiat-backed or algorithmic crypto systems.At the same time, the acquisition introduces significant execution and strategic risks.The valuation is based partly on projected revenue from products that are still expected to be operationalized after closing. Investors may also scrutinize whether MEHA has the operational expertise and financial resources necessary to transition into blockchain infrastructure and institutional DeFi products.Because the deal is structured as an all-stock transaction, dilution and integration risks could also remain key discussion points for shareholders. What To Watch Next Investors will likely monitor several upcoming catalysts tied to the proposed acquisition: Completion of due diligence and definitive agreements Regulatory approvals and closing timeline Details on commercialization plans for gold-backed stablecoins and DeFi products Potential institutional partnerships or ETF-related developments How Functional Brands integrates the BullionFX assets into its existing business structure Functional Brands stock price Original: Gold-Backed DeFi Acquisition Could Transform Functional Brands (MEHA) Into Blockchain Finance Player

Functional Brands Inc. Signs Binding Letter of Intent for the Acquisition of the Assets of BullionFX | Alchemy for $142.9 millionMay 11, 2026 8:00 AM
NewsfileStrategic acquisition of BullionFX | Alchemy assets is expected to position MEHA to develop a decentralized gold-backed financial ecosystem anchored by an auditable physical gold infrastructureLake Oswego, Oregon--(Newsfile Corp. - May 11, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, today announced it has executed a binding Letter of Intent ("LOI") to acquire the assets of BullionFX, including its core product Alchemy (collectively, the "BullionFX Assets"), in an all-stock transaction valued at approximately $142.9 million. The transaction contemplated by the LOI represents a strategic asset acquisition that is expected to provide the Company with access to technology, infrastructure and intellectual property associated with the BullionFX Assets, a blockchain-based financial ecosystem designed around auditable physical gold. Upon closing and operationalization, the BullionFX Assets are expected to support the development of products and infrastructure intended to enable retail and institutional users to access gold-linked digital financial applications, including payments, above-market yield and decentralized finance functionalities. The BullionFX Assets also include technology designed to facilitate interoperability between traditional financial systems and blockchain-based networks, including infrastructure developed on Ethereum. The acquisition of the BullionFX Assets is a natural extension of Functional Brands' core strategy of identifying innovative products and platforms that address emerging consumer needs and create long-term value for shareholders.The BullionFX Assets offer a comprehensive DeFi ecosystem in which every unit of digital value is directly tied to auditable physical gold held by independent custodians. The platform's architecture supports gold and USD backed stablecoins, lending and borrowing protocols, yield products, and cross-chain interoperability; all underpinned by real-time attestation of gold reserves through third-party institutional grade audit mechanisms."This transaction will be transformational for Functional Brands and our shareholders," said Eric Gripentrog, CEO of Functional Brands Inc. "The BullionFX Assets are expected to enable us to create what we believe is the most credible bridge between physical gold markets and decentralized finance. A fully auditable, real collateral with a protocol designed for institutional and retail participants alike. We are proud to formalize our commitment to bring this ecosystem into the public markets."Stephen Moss, creator and developer of the BullionFX Assets commented, "Bringing Alchemy to the Nasdaq will provide market access and institutional credibility our platform needs to accelerate its mission: delivering a stable, transparent financial ecosystem to retail users while bridging traditional and decentralized financial products. This convergence allows institutions to offer competitive products that the traditional sector alone cannot provide, as we enter a new era of financial innovation. We look forward to working with the MEHA management team to utilize the BullionFX Assets to launch a number of leading institutional products - including high-yielding exchange-traded funds denominated in gold and USD, and a USD stablecoin backed by physical gold, free from the counterparty risk inherent in holding USD within the centralized banking system."Simon Rahme, co-creator and developer, expanded, "Every major financial ecosystem requires a stable foundation. Blockchain has had the infrastructure - what it has lacked is the right asset to build on. Alchemy's blockchain has been built to run on $GOLD - physical metal, vaulted and audited - giving developers and institutions a settlement layer with five thousand years of monetary validation behind it."Under the terms of the binding LOI, the parties have agreed to work expeditiously toward definitive agreements, with final terms subject to completion of due diligence, regulatory review, approval by the respective boards of directors and other customary closing conditions. The $142.9 million valuation reflects BullionFX's technology infrastructure and early projected revenue from its suite of decentralized financial products.About Functional Brands Inc. (NASDAQ: MEHA)Functional Brands Inc. (NASDAQ: MEHA) is a health and wellness company dedicated to delivering innovative, evidence-based therapeutic solutions through its proprietary digital platform, Tru2u.health. The Company's mission is to make clinically meaningful health optimization accessible, personalized, and scalable for every member. Functional Brands develops and distributes a curated portfolio of functional health products, peptide therapies, and telehealth services designed to support metabolic health, longevity, and overall wellbeing.Contacts: FunctionalBrands@icrinc.comCautionary Note Regarding Forward-Looking StatementsThis news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, the ability of the parties to negotiate final terms of a definitive acquisition agreement, the closing of the contemplated asset purchase agreement, including expected conditions to closing which are anticipated to include regulatory approvals, valuations, and future shareholder approvals; the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the Company or BullionFX (collectively, the "LOI Parties") to terminate the LOI agreement; the effect of such termination; the outcome of any legal proceedings that may be instituted against LOI Parties or their respective directors or officers; the ability to obtain regulatory and other approvals and meet other closing conditions for the asset acquisition on a timely basis or at all, including the risk that any regulatory and other approvals required may not obtained on a timely basis or at all, or are obtained subject to conditions that are not anticipated or that could adversely affect the combined company or the expected benefits of the transaction; the ability to obtain any necessary approval by the Company's stockholders on the expected schedule of the transactions contemplated by the LOI; difficulties and delays in integrating BullionFX's assets in the Company; prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting the parties; potential adverse reactions or changes to business relationships resulting from the announcement of the LOI and future expected acquisition; uncertainty as to the long-term value of the common stock of the Company following the acquisition; the significant dilution to the Company's stockholder in connection with the acquisition; the continued availability of capital and financing following the potential acquisition transaction; the business, economic and political conditions in the markets in which the LOI Parties operate; and the fact that the Company's reported earnings and financial position may be adversely affected by tax and other factors.Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands' Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.# # #To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296855 Original: Functional Brands Inc. Signs Binding Letter of Intent for the Acquisition of the Assets of BullionFX | Alchemy for $142.9 million

MEHA..........................p/m

Functional Brands Inc. Announces Launch of GLP-Squared InjectionMay 6, 2026 8:00 AM
NewsfileProprietary Semaglutide + Tirzepatide Dual-Peptide Formulation Now Available Exclusively Through the Tru2u.health PlatformLake Oswego, Portland--(Newsfile Corp. - May 6, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a pioneer in next-generation health and wellness solutions, today announced the official launch of GLP-Squared Injection, its groundbreaking dual-peptide injectable combining Semaglutide and Tirzepatide in a single, synergistic formulation. GLP-Squared is now exclusively available to members of the Company's flagship digital health platform, Tru2u.health."The introduction of GLP-Squared Injection is a transformational milestone for Functional Brands and the members of Tru2u.health. By combining two of the most clinically effective peptides in metabolic medicine into a single, physician-guided protocol, we are offering our members a powerful new tool to achieve their health goals. Tru2u.health was built to be the home of innovation in personalized health, and GLP-Squared exemplifies exactly that commitment," said Eric Gripentrog, CEO of Functional Brands Inc.A New Standard in GLP-1-Based Metabolic TherapyGLP-Squared Injection represents a significant advancement in metabolic and weight-management medicine. By combining Semaglutide-a proven GLP-1 receptor agonist-with Tirzepatide's dual GLP-1/GIP receptor agonist activity, the formulation is designed to deliver amplified appetite regulation, improved glycemic control, and enhanced adipose tissue reduction through complementary and synergistic mechanisms of action.The goal of offering patients a precision-optimized, clinician-supervised peptide therapy that goes beyond what single-agent GLP-1 products can achieve.Key Highlights: GLP-Squared InjectionDual-Mechanism Action: Combines Semaglutide (GLP-1 agonist) with Tirzepatide (GLP-1 + GIP dual agonist) for a multi-receptor metabolic impact that addresses appetite, insulin sensitivity, and fat metabolism simultaneously.Precision Peptide Formulation: Clinically calibrated dosing ratios developed to maximize synergy while maintaining an individualized safety profile for each Tru2u.health member.Clinician-Supervised Protocol: GLP-Squared is prescribed and monitored by licensed healthcare providers through the Tru2u.health telehealth infrastructure, ensuring medically appropriate oversight at every step.Platform-Exclusive Access: GLP-Squared Injection is exclusively available through Tru2u.health, underscoring the Company's commitment to integrating cutting-edge therapeutics within its personalized digital health ecosystem.Streamlined Member Experience: From initial consultation and labs to prescription fulfillment and ongoing coaching, members receive end-to-end support directly through the Tru2u.health platform.Tru2u.health: The Platform Powering Personalized Health at ScaleTru2u.health is Functional Brands' proprietary digital health platform designed to connect members with licensed clinicians, evidence-based therapeutics, and personalized wellness protocols-all in one place. Tru2u.health serves as the exclusive conduit for GLP-Squared Injection, allowing members to:Complete telehealth consultations with credentialed providersAccess required laboratory screening and results reviewReceive GLP-Squared prescriptions with direct fulfillmentEngage with ongoing metabolic coaching, nutrition guidance, and progress monitoringBenefit from a fully integrated, data-driven health journey personalized to their biology and goalsThe launch of GLP-Squared on Tru2u.health marks a pivotal expansion of the platform's therapeutic offerings, reinforcing its position as a premier destination for members seeking clinically sophisticated, results-driven health optimization.Addressing a Multi-Billion Dollar Market OpportunityThe global GLP-1 therapy market is among the fastest-growing segments in healthcare, with demand for Semaglutide and Tirzepatide-based therapies continuing to accelerate. Functional Brands is strategically positioned to capture meaningful market share through the Tru2u.health platform, which offers a differentiated, end-to-end member experience that commodity pharmacy channels cannot replicate.GLP-Squared Injection further distinguishes Tru2u.health by offering a proprietary dual-peptide option not available through traditional retail or mail-order pharmacy routes, creating a meaningful competitive moat and a compelling driver of member acquisition and retention.AvailabilityGLP-Squared Injection is available immediately to qualifying Tru2u.health members following clinician evaluation and approval. Interested individuals may visit www.Tru2u.health to begin their intake, complete telehealth onboarding, and determine eligibility for the GLP-Squared protocol.About Functional Brands Inc. (MEHA)Functional Brands Inc. (NASDAQ: MEHA) is a health and wellness company dedicated to delivering innovative, evidence-based therapeutic solutions through its proprietary digital platform, Tru2u.health. The Company's mission is to make clinically meaningful health optimization accessible, personalized, and scalable for every member. Functional Brands develops and distributes a curated portfolio of functional health products, peptide therapies, and telehealth services designed to support metabolic health, longevity, and overall wellbeing.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those implied by the forward-looking statements. Functional Brands Inc. undertakes no obligation to publicly update or revise any forward-looking statements as a result of new information, future events, or otherwise, except as required by law.INVESTOR & MEDIA CONTACT
Functional Brands Inc. | Investor Relations
ir@functionalbrands.com
www.Tru2u.health | NASDAQ: MEHATo view the source version of this press release, please visit https://www.newsfilecorp.com/release/296153 Original: Functional Brands Inc. Announces Launch of GLP-Squared Injection

Tru2u.health Expands Digital Health Platform with the Addition of NAD+ - The Cellular Energy Molecule Transforming Modern WellnessApril 29, 2026 8:00 AM
NewsfileLake Oswego, Oregon--(Newsfile Corp. - April 29, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced a significant expansion of its digital health platform, www.Tru2u.health, with the addition of NAD+ (Nicotinamide Adenine Dinucleotide) therapy. This milestone enhances Tru2u.health's already comprehensive suite of solutions that includes peptide protocols, GLP-1-based weight management, and board-certified telehealth support."The launch of NAD+ therapy on Tru2u.health is a natural evolution of our commitment to delivering the most impactful, science-backed wellness solutions available," said Eric Gripentrog, Chief Executive Officer of Functional Brands Inc. "NAD+ sits at the foundation of how our cells produce energy and repair themselves. By making it accessible through our clinically guided platform, we're giving our patients a powerful new tool to optimize their health at the cellular level - and reinforcing Tru2u.health as the destination for comprehensive, medication-based wellness care."What Is NAD+? The Science Behind the MoleculeNAD+ (Nicotinamide Adenine Dinucleotide) is a naturally occurring coenzyme found in every living cell. It is essential to life - playing a central role in energy metabolism, DNA repair, and the activation of proteins that regulate cellular health and longevity. Without adequate NAD+, cells cannot efficiently generate the energy needed to perform their core functions. [1]Research has identified NAD+ as one of the most important molecules in human biology, with declining NAD+ levels linked to the hallmarks of aging, metabolic dysfunction, and diminished physical and cognitive performance. [1,2] Key functions of NAD+ include:Cellular Energy Production - NAD+ is a critical cofactor in mitochondrial function, driving the production of ATP, the body's primary energy currency. Higher NAD+ levels are associated with greater endurance, vitality, and metabolic efficiency. [1]DNA Repair & Genome Stability - NAD+ fuels PARP (poly-ADP-ribose polymerase) enzymes, which detect and repair DNA damage caused by oxidative stress, UV radiation, and normal aging. Robust NAD+ availability helps maintain genomic integrity over time. [3]Sirtuin Activation - NAD+ is required to activate sirtuins, a family of proteins described by researchers at MIT and Harvard as central "longevity regulators." Sirtuins govern inflammation response, fat metabolism, stress resistance, and circadian rhythm regulation. [2,4]Neuroprotection & Cognitive Function - The brain is among the most metabolically demanding organs in the body. Peer-reviewed research has identified increasing NAD+ levels as a promising strategy for preserving cognitive ability and protecting against age-related neurological decline. [5,6]Muscle Recovery & Physical Performance - By supporting mitochondrial efficiency and reducing oxidative stress in muscle tissue, NAD+ can aid post-exercise recovery and sustained physical output. [1]Metabolic Health - NAD+ plays a regulatory role in insulin sensitivity and fat oxidation, making it a natural complement to GLP-1 and metabolic wellness programs. [8]NAD+ levels naturally decline with age - research documents a drop of approximately 40-50% between youth and midlife, with further decline into older age - making therapeutic replenishment an increasingly compelling option for adults seeking to preserve vitality and longevity. [9,10]Why NAD+ Belongs on Tru2u.healthThe addition of NAD+ therapy deepens Tru2u.health's clinical offering and creates powerful synergies across the platform's existing pillars:Metabolic Synergy - NAD+ + GLP-1 Programs: NAD+'s role in insulin sensitivity and fat metabolism [8] makes it an ideal companion therapy for patients in GLP-1-based weight management programs.Performance & Recovery - NAD+ + Peptide Protocols: Combining NAD+ with peptide solutions supports cellular repair, tissue recovery, and sustained physical performance. [1,3]Safe, Personalized Delivery - NAD+ + Telehealth Oversight: Board-certified providers on Tru2u.health evaluate each patient individually, ensuring NAD+ therapy is administered appropriately, safely, and in alignment with the patient's broader health goals.A Fully Integrated Digital Health Platformwww.Tru2u.health is a digital health platform dedicated to helping individuals achieve their health goals through medication-based treatment, clean supplementation, and clinically guided wellness solutions. The platform's five core pillars include:NAD+ Therapy - Clinically supervised NAD+ programs designed to support cellular energy, healthy aging, cognitive performance, and metabolic function.Peptide Solutions - Access to emerging peptide-based protocols designed to support metabolic health and performance, where clinically appropriate and compliant.GLP-1-Based Weight Management - Physician-guided programs utilizing GLP-1 therapies as part of a structured, medically supervised treatment plan.Board-Certified Telehealth Support - Ongoing clinical oversight, virtual consultations, and personalized care plans delivered through a secure digital experience.Clean Supplements - Science-backed, premium formulations focused on ingredient integrity and transparency.By integrating medication-based treatment with clean supplementation and expert clinical oversight, www.Tru2u.health simplifies what has historically been a fragmented wellness journey.Influencer-Led National LaunchThe expansion is being supported by an initial wave of social media influencers across health, fitness, lifestyle, and performance categories. These partnerships are designed to deliver authentic education around responsible wellness solutions, including the science and benefits of NAD+ therapy.This digitally native go-to-market approach positions www.Tru2u.health to scale efficiently while maintaining clinical integrity and regulatory compliance.Built for Responsible, Scalable GrowthThe www.Tru2u.health platform is structured to:Provide individualized treatment plans tailored to each patient's unique health goalsSupport subscription-based, recurring revenue modelsLeverage influencer-driven digital acquisition strategiesExpand into additional therapeutic and wellness categories over timewww.Tru2u.health is now live and onboarding patients nationwide for NAD+ therapy and all platform services, subject to applicable state telehealth and prescribing regulations.About Functional Brands Inc., Kirkman® and Tru2u.health
Functional Brands Inc. is a health and wellness company focused on acquiring and growing science-based consumer brands. With a portfolio that includes trusted names like Kirkman®, P2i by Kirkman®, Tru2u.Health™; Functional Brands is committed to providing high-quality, effective solutions that support healthier lives. Kirkman® has been the leader in Ultratested® supplements since 1949, setting the gold standard in purity and hypoallergenic formulation. Our rigorous standards ensure that even the most sensitive communities-including those who cannot tolerate other supplements-can thrive from our formulations. With more than 70 years of clean science behind every product, Kirkman® is trusted by practitioners and patients worldwide.Tru2u.health is a personalized health and wellness platform that connects consumers with trusted products, providers and resources tailored to their individual health journeys. Built on the conviction that no two paths to health are alike, Tru2u.health delivers guidance and solutions that are genuinely true to you. For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health Investor Relations Contact:
FunctionalBrands@icrinc.comScientific References
The following peer-reviewed studies and clinical publications support the scientific claims made in this press release:
[1] Covarrubias et al., "Role of NAD+ in regulating cellular and metabolic signaling pathways," NIH/PMC
[2] Imai S. & Guarente L., "It takes two to tango: NAD+ and sirtuins in aging/longevity control," npj Aging and Mechanisms of Disease, 2016
[3] Bohr V.A., "Promising Results With NAD Supplementation in Rare Diseases With Premature Aging and DNA Damage," Aging Cell, 2025
[4] Guarente L., "Sirtuins, aging and diseases," BMC Proceedings, 2012; MIT Glenn Laboratories
[5] Campbell J.M., "Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts," Nutrients, 2022 (NIH/PMC)
[6] Zhao et al., "NAD+ improves cognitive function and reduces neuroinflammation," Journal of Neuroinflammation, 2021 (NIH/PMC)
[7] Tarantini et al., "Nicotinamide mononucleotide supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses," Redox Biology, 2019
[8] Gomes et al., "Dysregulation of NAD+ Metabolism Links Mitochondrial Dysfunction to Aging and Disease," Targeting NAD+ in Metabolic Disease, NIH/PMC
[9] Massudi et al., "The Plasma NAD+ Metabolome Is Dysregulated in Normal Aging," NIH/PMC
[10] Campbell et al., PRISMA-guided systematic review of NAD supplementation, ScienceDirect, 2026Cautionary Note Regarding Forward Looking Statements
This news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control.Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands' Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294829
Original: Tru2u.health Expands Digital Health Platform with the Addition of NAD+ - The Cellular Energy Molecule Transforming Modern Wellness

Functional Brands Inc. Enters Strategic Partnership with partnrup.ai to Accelerate Growth of Tru2u.healthApril 22, 2026 8:00 AM
NewsfileLake Oswego, Oregon--(Newsfile Corp. - April 22, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced a strategic technology partnership with partnrup.ai, a next-generation artificial intelligence platform purpose-built to support and improve partner-driven customer acquisition. The partnership will deploy partnrup.ai's full technology stack on behalf of Tru2u.health, a digital health platform dedicated to helping individuals achieve their health goals through medication-based treatment, clean supplementation and clinically guided wellness solutions.The integration of partnrup.ai's AI platform represents an important step in scaling Tru2u.health's partner marketing efforts. Tru2u.health connects consumers with personalized health solutions, trusted wellness products (including nutraceuticals, peptides and GLP-1's) and vetted health providers — Partnrup.ai's platform enables continuous AI-powered partner discovery, real-time traffic evaluation, and measurement across campaigns, helping the team better understand and refine how they reach relevant audiences — Functional Brands Inc. expects to materially improve the platform's cost-per-acquisition and revenue-per-visitor metrics."This strategic partnership directly supports our mission to build scalable, profitable health and wellness assets," said Eric Gripentrog, CEO of Functional Brands Inc. "Partnrup.ai gives Tru2u.health the AI infrastructure to grow traffic intelligently — attracting consumers who are genuinely seeking what we offer — and that precision should translate directly into revenue and long-term platform value for our shareholders." The Tru2u.health platform was designed around the principle that every individual's health journey is unique and personal. That mission demands that acquisition channels deliver consumers who are authentically aligned with the platform's offerings. Partnrup.ai's proprietary matching algorithms and behavioral scoring models ensure that partner-driven traffic is evaluated using intent-based signals to help improve alignment between content, creators and audience engagements. Under the terms of the partnership, partnrup.ai will serve as the primary AI-powered partner technology provider for Tru2u.health's marketing and partner programs. The integration is expected to be fully operational within 10 days, with initial performance data and key conversion metrics available to management on a rolling basis. "Tru2u.health is a strong example of how brands can use AI to better identify and connect with relevant audiences. We're excited to support their team with technology that improves partner discovery, traffic quality, and measurement in a way that is scalable and transparent," said Jessica Thorpe, CEO of partnrup.ai. "We are proud to partner with Functional Brands Inc. to demonstrate what intelligent, data-driven partner technology can do for a health and wellness brand at scale." Functional Brands Inc. views this partnership as a scalable model that may be extended to other platforms within its portfolio. Management believes that the demonstrated results from the Tru2u.health deployment will create additional opportunities to leverage partnrup.ai's technology across the Company's broader brand ecosystem, further enhancing the digital revenue capabilities that underpin MEHA's growth strategy.About Functional Brands Inc., Kirkman® and Tru2u.health
Functional Brands Inc. is a health and wellness company focused on acquiring and growing science-based consumer brands. With a portfolio that includes trusted names like Kirkman®, P2i by Kirkman®, Tru2u.Health™; Functional Brands is committed to providing high-quality, effective solutions that support healthier lives. Kirkman® has been the leader in Ultratested® supplements since 1949, setting the gold standard in purity and hypoallergenic formulation. Our rigorous standards ensure that even the most sensitive communities-including those who cannot tolerate other supplements-can thrive from our formulations. With more than 70 years of clean science behind every product, Kirkman® is trusted by practitioners and patients worldwide.Tru2u.health is a personalized health and wellness platform that connects consumers with trusted products, providers and resources tailored to their individual health journeys. Built on the conviction that no two paths to health are alike, Tru2u.health delivers guidance and solutions that are genuinely true to you. For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health About partnrup.ai
partnrUP is an AI- powered influencer marketing platform that helps brands discover creators, manage content, and drive measurable results from creator partnerships. The platform enables marketers to scale campaigns, streamline workflows, and turn creator content into a repeatable growth channel across social and commerce environments. It recently acquired Novel to help bring shoppable video to DTC, Shopify Storefronts, and the Shop App Discovery Feed.partnrup.ai is an artificial intelligence platform engineered for partner-driven customer acquisition. By combining intelligent partner discovery, real-time traffic optimization, automated attribution, and brand safety monitoring, partnrup.ai enables brands to grow qualified customer acquisition at scale. For more information, visit partnrup.ai.Investor Relations Contact:
FunctionalBrands@icrinc.comCautionary Note Regarding Forward Looking Statements
This news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control.Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands' Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/293717
Original: Functional Brands Inc. Enters Strategic Partnership with partnrup.ai to Accelerate Growth of Tru2u.health

Functional Brands Inc. Unveils New Weight Loss Support Bundle to Boost Digestion, Metabolism, and Muscle PreservationApril 17, 2026 8:00 AM
NewsfileNon-Prescription Product Bundle Targets Holistic Weight Loss with Proven Ingredients for Effective ResultsLake Oswego, Oregon--(Newsfile Corp. - April 17, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced the launch of its new Kirkman Weight Loss Support Bundle. Designed to support a healthy and sustainable weight loss journey, this bundle combines three scientifically-backed products to target key areas of digestion, metabolism, and muscle preservation.The Weight Loss Support Bundle includes:Kirkman's Pro Bio Gold - A powerful probiotic formula that promotes optimal gut health. By improving digestion, enhancing nutrient absorption, and reducing bloating, Pro Bio Gold helps users maintain a healthy digestive system, which is critical for weight management and overall well-being.Kirkman's L-Carnitine - A key player in fat metabolism and energy production. L-Carnitine helps the body efficiently convert fat into energy, supporting fat loss while boosting physical performance. This product helps users stay energized during their weight loss journey while maximizing fat-burning potential.Kirkman's L-Glutamine - Known for its ability to curb sugar cravings, L-Glutamine also supports lean muscle preservation during weight loss. By reducing the urge for unhealthy snacks and maintaining muscle mass, this ingredient helps individuals maintain a balanced, effective weight loss plan without sacrificing muscle strength."Our Weight Loss Support Bundle is designed to be a comprehensive, non-prescription solution for anyone looking to improve their weight management and achieve lasting results," said Eric Gripentrog, CEO of Functional Brands Inc. "With a growing demand for natural, non-prescription products that support weight loss, we've carefully curated a bundle that addresses digestion, metabolism, and muscle preservation-three crucial components for successful weight management."This bundle was developed with those who are serious about making lasting health changes. By addressing the foundational needs of digestion, metabolism, and muscle maintenance, the Weight Loss Support Bundle is perfect for anyone looking to kickstart or enhance their weight loss journey.Key Benefits of the Weight Loss Support Bundle:Promotes better digestion and reduced bloating with Kirkman's Pro Bio GoldSupports fat metabolism and energy production with Kirkman's L-CarnitineCurbs sugar cravings and supports lean muscle with Kirkman's L-GlutamineIdeal for those looking for a holistic approach to healthy, sustainable weight lossThe Functional Brands Inc. by Kirkman Weight Loss Support Bundle is now available for purchase through Kirkman's website at www.kirkmangroup.com/products/weight-loss-support-bundle and through practitioners.For more information, please visit www.kirkmangroup.com or call 1-800-245-8282.About Functional Brands Inc. and Kirkman®
Functional Brands Inc. is a health and wellness company focused on acquiring and growing science-based consumer brands. With a portfolio that includes trusted names like Kirkman®, P2i by Kirkman®, Tru2u.Health™; Functional Brands is committed to providing high-quality, effective solutions that support healthier lives. Kirkman® has been the leader in Ultratested® supplements since 1949, setting the gold standard in purity and hypoallergenic formulation. Our rigorous standards ensure that even the most sensitive communities-including those who cannot tolerate other supplements-can thrive from our formulations. With more than 70 years of clean science behind every product, Kirkman® is trusted by practitioners and patients worldwide.For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health.Investor Relations Contact:
FunctionalBrands@icrinc.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/293046
Original: Functional Brands Inc. Unveils New Weight Loss Support Bundle to Boost Digestion, Metabolism, and Muscle Preservation

Out with break-even.

News can mean nothing to any one stock, $AIXI had news on Tuesday of last week and it only started running on Thursday, MEHA has had an unusual volume, whether it will continue to run or not, it is not in our control, that is why you buy small position nothing major, but it has 200% gains in it regardless.

Can’t find any news on this one except earnings/revs improvements.
In any case got some lol
MEHA

Looks like easy 200% from here by end of the week.

Took a small position.

MEHA.................https://stockcharts.com/sc3/ui/?s=MEHA&p=w&b=5&g=0&id=p86431144783

Functional Brands Announces Fourth Quarter and Full-Year 2025 Financial ResultsMarch 30, 2026 8:00 AM
NewsfileFourth quarter net income improved to $0.9 million compared to a net loss of $0.3 million in the prior year periodLake Oswego, Oregon--(Newsfile Corp. - March 30, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the fourth quarter and full-year ended December 31, 2025.Fourth Quarter 2025 highlightsRevenue of $1.50 million compared to $1.68 million in the prior year period, a decrease of approximately 11.0%. This decrease was primarily due to the shift in our Amazon business model from a reseller model to a direct-to-consumer approach through our own Amazon Seller's Central account. Gross profit was $0.67 million compared to $0.99 million in the prior year period. Gross margin of 44.9% was down 1400 basis points versus the prior year period due to changes in the Amazon business model and inventory adjustments related to our transition out of the hemp business. Net income of $0.9 million or $0.01 per diluted share compared to a net loss of $0.3 million and $(0.08) per diluted share in the prior year period. Full Year 2025 highlightsRevenue of $6.61 million compared to $6.57 million in the prior year, an increase of approximately 0.7%, reflecting the inherent stability of the Kirkman business.Gross profit was $3.48 million compared to $3.61 million in the prior year. Gross margin of 52.7% was down 220 basis points versus the prior year due to inventory adjustments related to our transition out of the hemp business.Net income of $0.8 million or $0.01 per diluted share compared to a net loss of $0.6 million and $(0.08) per diluted share in the prior year."We were pleased to deliver another year of strong bottom-line results as we continue to transform our business model," said Eric Gripentrog, CEO of Functional Brands Inc. "Over the past several months, we've executed a series of key initiatives that mark a pivotal period in the Company's evolution and establish a strong foundation for sustainable, profitable growth in the future. We achieved significant strategic breakthroughs that differentiate us in the marketplace and demonstrate our commitment to innovation across multiple fronts. "In February, we launched Tru2u.health, our comprehensive digital health platform that integrates peptide solutions, GLP-1-based weight management programs, board-certified telehealth support, and clean supplements into a seamless consumer experience, providing us with a scalable, digitally native growth engine. We also expanded our Kirkman brand portfolio with two innovative product bundles - our Skin, Beauty & Anti-Aging Bundle in December and our Detox Aid Bundle in January. Additionally, we forged a strategic partnership with iHerb to make P2i by Kirkman available to international consumers across Asia, Europe, the Middle East, and Latin America, dramatically expanding our addressable market for the world's cleanest prenatal vitamin. These accomplishments demonstrate strong execution against our strategic goals and underscore our commitment to our mission of 'Making Everyone Healthy Again'."About Functional Brands Inc.Functional Brands Inc. is a health and wellness company focused on acquiring and growing science-based consumer brands. With a portfolio that includes trusted names like Kirkman®, P2i by Kirkman®, Tru2u.Health™; Functional Brands is committed to providing high-quality, effective solutions that support healthier lives. For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health Investor Relations Contact:
FunctionalBrands@icrinc.comCautionary Note Regarding Forward Looking StatementsThis news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control.Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands' Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.FUNCTIONAL BRANDS INC.
CONSOLIDATED BALANCE SHEETS (AUDITED)
(In U.S. dollars, except share data or otherwise noted)
 December 31,
2025
December 31,
2024
Assets 



Current assets: 



Cash $2,726,696
$211,642
Accounts receivable, net 
518,474

303,471
Inventories, net 
1,549,511

1,709,458
Prepaid expenses and other current assets 
392,999

45,112
Deferred offering costs 
-

588,641
Total current assets 
5,187,680

2,858,324
Noncurrent assets: 
 

 
Property and equipment, net 
37,379

49,564
Right-of-use assets, net 
1,667,693

2,000,092
Intangible assets, net 
1,397,411

1,443,541
Goodwill 
818,139

818,139
Total non-current assets 
3,920,622

4,311,336
Total assets $9,108,302
$7,169,660

 
 

 
Liabilities and stockholders' equity / (deficit) 
 

 
Current liabilities: 
 

 
Accounts payable and accrued liabilities $1,554,243
$1,956,165
Line of credit 
8,109

32,235
SBA loan, current 
3,595

3,436
Lease liabilities, current 
371,272

291,213
Other current liabilities 
41,828

35,332
Derivative liabilities 
3,306,745

-
Payable for acquisition, current 
-

2,342,366
Loans payable (related party), current 
61,642

370,703
Loans payable 
402,650

171,500
Total current liabilities 
5,750,084

5,202,950
Non-current liabilities: 
 

 
Lease liabilities, net of current 
1,435,505

1,844,819
SBA loan, net of current 
136,873

140,468
Loan payable (related party), net of current 
244,509

-
Convertible debenture 
-

100,000
Total non-current liabilities 
1,816,887

2,085,287
Total liabilities 
7,566,971

7,288,237

 
 

 
Stockholders' equity / (deficit) 
 

 
Series A Preferred stock, par value $0.001 stated value $100, 100,000 and 0 shares authorized as of December 31, 2025 and 2024; 87,445 and 0 shares issued and outstanding, respectively 
87

-
Series B Preferred stock, par value $0.001 stated value $100, 80,000 and 0 shares authorized as of December 2025 and 2024; 28,475 shares issued and 0 outstanding, respectively 
28

-
Common stock, par value $0.00001, 220,000,000 shares authorized; 18,704,649 and 6,694,880 shares issued and outstanding at December 31, 2025 and 2024 
187

67
Additional paid-in capital 
8,522,354

7,542,286
Accumulated deficit 
(6,981,325)
(7,660,930)Total stockholders' equity / (deficit) 
1,541,331

(118,577)Total liabilities and stockholders' equity / (deficit) $9,108,302
$7,169,660
 FUNCTIONAL BRANDS INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In U.S. dollars, except share data or otherwise noted)
 (UNAUDITED)
Three Months Ended
December 31,
(AUDITED)
Year Ended
December 31,

 2025
2024
2025
2024
Revenue, net of returns $1,494,521
$1,680,096
$6,611,484
$6,566,455
Cost of goods sold 
823,766

690,623

3,127,518

2,959,609
Gross profit 
670,755

989,473

3,483,966

3,606,846
Operating expenses 
 

 

 

 
Sales and marketing 
169,869

121,601

632,414

576,315
General and administrative expenses 
1,633,636

1,003,619

4,250,124

3,259,623
Total operating expenses 
1,803,505

1,125,220

4,882,538

3,835,938
Operating income / (loss) 
(1,132,750)
(135,747)
(1,398,572)
(229.092)Interest expense 
(80,982)
(142,284)
(402,398)
(331.836)Other income - ERTC refund 
-

-

419,947

-
Other income 
-

-

112

-
Interest income 
1,352

281

74,696

1,572
Change in fair value of derivative liabilities 
7,358,935

-

7,358,935

-
Loss on issuance of preferred stock derivative liability 
(5,294,242)
-

(5,294,242)
-
Total other income / (expenses) 
1,985,063

(142,003)
2,157,050

(330.264)Net income / (loss) $852,313
$(277,750)$758,478
$(559,356)Net income (loss) per share of common stock attributable to common stockholders 
 

 

 

 
Basic $0.08
$(0.08)$0.08
$(0.08)Diluted $0.01
$(0.08)$0.01
$(0.08)Weighted average shares used in computing net loss per share of common stock 
 

 

 

 
Basic 
8,241,266

6,694,880

8,241,266

6,694,880
Diluted 
85,120,861

6,694,880

85,120,861

6,694,880
 FUNCTIONAL BRANDS INC.CONSOLIDATED STATEMENTS OF CASH FLOW (AUDITED)(In U.S. dollars, except share data or otherwise noted)
 Year Ended
December 31,

 2025
2024

 



Cash flows from operating activities: 



Net income (loss) $758,478
$(559,356)Reconcile net income (loss) to cash (used in) provided by operating activities 
 

 
Allowance for doubtful accounts receivable 
(3,796)
(32,491)Allowance for inventory obsolescence 
53,855

(14,206)Depreciation of property and equipment 
20,698

48,371
Amortization of right-of-use assets 
332,399

306,935
Amortization of intangible assets 
46,130

46,130
Financing expense on warrant issuance 
45,413

-
Stock-based compensation 
543,068

414,900
Change in fair value of derivative liabilities 
(7,358,935)
-
Loss on issuance of preferred stock of derivative liabilities 
5,294,242

-
Issuance of shares for note extension 
80,500

-
Issuance of common stock for convertible debenture 
122,331

-
Issuance of shares for financing expense 
50,629

-
Changes in operating assets and liabilities: 
 

 
Accounts receivable 
(211,207)
(100,042)Inventories 
106,092

(1,233)Prepaid expenses and other current assets 
(347,887)
27,329
Accounts payable and accrued liabilities 
(480,795)
132,161
Other current liabilities 
6,496

(5,493)Lease liabilities 
(329,255)
(261,015)Net cash (used in) provided by operating activities 
(1,271,544)
1,990

 
 

 
Cash flows from investing activities: 
 

 
Purchase of property and equipment 
(8,513)
(1,881)Net cash used in investing activities: 
(8,513)
(1,881)
 
 

 
Cash flows from financing activities: 
 

 
Deferred offering costs 
(1,721,228)
(163,125)Proceeds from loans 
489,324

301,500
Payments for payable for acquisition 
(2,342,366)
(255,002)Proceeds from debt facilities 
99,733

180,662
Repayment of loans 
(422,727)
(6,931)Proceeds from issuance of preferred stock 
8,000,000

-
Buyback of preferred stock 
(180,330)
-
Line of credit repayment 
(123,859)
(216,742)SBA loan repayment 
(3,436)
(3,264)Net cash provided by (used in) financing activities 
3,795,111

(162,902)
 
 

 
Increase (decrease) in cash 
2,515,054

(162,793)Cash beginning of period 
211,642

374,435
Cash, end of period $2,726,696
$211,642

 
 

 
Supplemental disclosures of cash flow information 
 

 
Cash paid for interest $401,411
$224,428

 
 

 
Non-cash investing and financing activities 
 

 
Recognition of derivative liability of preferred stock $13,294,242
$-
Conversion of preferred stock resulting in a non-cash reduction of the derivative liability recorded to APIC 
2,628,242

-
Fair value adjustment decreasing derivative liability 
7,358,935

 
Change in Preferred Stock 
115

-
Conversion of preferred stock 
112

-
Deferred offering costs 
(2,309,869)
-
Declaration of preferred stock dividend recorded as an increase in accrued liabilities 
78,873

-
Common stock issued for convertible note payable and accrued interest 
122,331

-
Loan payable, related party $225,000
$-
 To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290371
Original: Functional Brands Announces Fourth Quarter and Full-Year 2025 Financial Results

Functional Brands Inc. Expands International Access for the P2i(TM) by Kirkman(R) Through iHerbMarch 20, 2026 8:00 AM
NewsfileiHerb Becomes Global Distribution Partner for P2i™ by Kirkman®Lake Oswego, Oregon--(Newsfile Corp. - March 20, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that P2i™ Prenatal Multivitamin & Multimineral, is now officially available at iHerb, one of the world's leading online specialty retailers for health and wellness. Known for its seamless global distribution capabilities, iHerb will make P2i™ by Kirkman® accessible to families in new countries and regions around the world.This partnership represents a major milestone for Functional Brands Inc. and Kirkman®'s mission to provide ultra-clean, scientifically advanced supplements to those who need them most. With growing concern over the toxins that may be present in prenatal supplements, iHerb offers practitioners and consumers a trusted source for products that are setting the global gold standard for pregnancy nutrition."We're thrilled to expand access of P2i™ by Kirkman® through iHerb," said Eric Gripentrog, CEO of Functional Brands Inc. "This platform gives international customers a safe, reliable way to receive one of the world's cleanest prenatal vitamins-no matter where they live."An article published on the iHerb Wellness Hub emphasizes the critical need for prenatal supplement purity and safety. The article highlights the importance of reducing the harmful exposure to environmental contaminants and recommends that consumers look for the "P2i" seal on vitamins to demonstrate that it has been tested and is free of toxic chemicals. Why P2i Is in a League of Its OwnP2i™ by Kirkman® aligns with the standards of FIGO (International Federation of Gynecology and Obstetrics) and it is uniquely engineered to protect both mother and baby from harmful contaminants. P2i™ by Kirkman® is tested for over 160 potential threats, including:24 heavy metals120 toxicants and chemicals9 major allergens10 microbiological contaminantsAs studies continue to expose the risks of contaminants like lead, mercury, cadmium, and arsenic in prenatal supplements, We believe P2i™ can help save lives and dramatically improve health outcomes for pregnant women around the world.What This Means for Global ConsumersInternational Availability: Through iHerb, P2i™ can now be purchased and delivered in countries across Asia, Europe, the Middle East, and Latin America.Trusted Distribution: iHerb's reputation for fast, safe, and transparent fulfillment ensures the integrity of every order.Advanced Testing Standards: P2i™ by Kirkman® is developed with a testing approach aligned to the International Federation of Gynecology and Obstetrics (FIGO) positioning on prenatal safety and contaminant exposure.No Compromise on Ingredients: Formulated without GMOs, titanium dioxide, dyes, or unnecessary fillers and manufactured in a FDA registered, cGMP facilityWhere to Buy P2i InternationallyP2i™ by Kirkman® is now available globally through iHerb. Visit www.iherb.com and search "Kirkman P2i" to place your order.About Functional Brands Inc. and Kirkman® Functional Brands Inc., the parent company of Kirkman®, is committed to developing clinically aligned health products that bridge science, practitioner trust, and patient safety. Every product under the Functional Brands umbrella is formulated with a commitment to transparency, testing, and results.Kirkman® has been the leader in Ultratested® supplements since 1949, setting the gold standard in purity and hypoallergenic formulation. Our rigorous standards ensure that even the most sensitive communities—including those who cannot tolerate other supplements—can thrive from our formulations. With more than 70 years of clean science behind every product, Kirkman® is trusted by practitioners and patients worldwide.Investor Relations Contact:
FunctionalBrands@icrinc.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/289293
Original: Functional Brands Inc. Expands International Access for the P2i(TM) by Kirkman(R) Through iHerb

Functional Brands Inc. to Participate in the 38th Annual ROTH ConferenceMarch 16, 2026 8:00 AM
NewsfileLake Oswego, Oregon--(Newsfile Corp. - March 16, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that it will participate in the 38th Annual ROTH Conference, taking place March 22-24, 2026, in Dana Point, California.Eric Gripentrog, Chief Executive Officer & Director, and David R. Wells, Financial Counsel, will participate in the event and meet with investors. The conference will feature a combination of one-on-one and small-group meetings, analyst-led fireside conversations, industry presentations, and panel discussions. To learn more and submit a registration request, visit https://ibn.fm/Roth2026Registration.About Functional Brands Inc.Functional Brands Inc. is a dedicated provider of quality wellness solutions, offering products designed to support a wide range of health and fitness goals. Through a commitment to science-backed ingredients and holistic formulations, Functional Brands Inc. is dedicated to helping individuals improve their health, performance, and overall well-being.For more information, visit: www.functionalbrandsinc.com; www.kirkmangroup.com; www.tru2u.health or call 1-800-245-8282.Investor Relations Contact:
FunctionalBrands@icrinc.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/288599
Original: Functional Brands Inc. to Participate in the 38th Annual ROTH Conference

MEHA...........................................https://stockcharts.com/sc3/ui/?s=MEHA&p=W&b=5&g=0&id=p86431144783

https://investorshub.advfn.com/stock-market/NASDAQ/functional-brands-MEHA/trades

ALERTS100%to10000%GAIN
Post#
712849
of 715874
MEHA~~.2295, ready to start here, target .50-$1.00 pps,,Momentum for MEHA is strongly bullish.

Functional Brands Inc. Introduces Kirkman's(R) Exciting New Restorative Sleep Bundle for Deep, Refreshing Sleep Without GrogginessFebruary 17, 2026 8:00 AM
NewsfileA Science-Backed Solution to Support Relaxation and Nervous System BalanceLake Oswego, Oregon--(Newsfile Corp. - February 17, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, is thrilled to announce the launch of the new Kirkman® Restorative Sleep Bundle, a carefully formulated combination designed to promote deep, restorative sleep and calm the nervous system-without the morning grogginess commonly associated with sleep aids. The bundle features Herbal Sleep Aid (melatonin-free), GABA 250, and L-Theanine, all selected based on clinical evidence for their synergistic roles in supporting relaxation, reducing tension, and enabling smooth transitions into restful sleep."At Functional Brands Inc, we believe true health starts with restorative sleep. This bundle was created not just to help people fall asleep, but to truly recharge the mind and body overnight-naturally and without harsh ingredients," said Eric Gripentrog, CEO of Functional Brands Inc. "With so many individuals struggling to get quality sleep, we're proud to offer a clean, effective solution that helps people wake up ready to thrive."Herbal Sleep Aid contains a potent blend of traditional botanicals known for their calming properties:Lemon Balm (Melissa officinalis), a member of the mint family used since the Middle Ages, helps reduce stress and occasional anxiety while promoting restful sleep and easing digestive discomfort [1].Chamomile, one of the oldest medicinal herbs, is widely recognized for its calming effects on the nervous system and its ability to alleviate insomnia and anxiety. A systematic review has shown chamomile supplementation significantly improves sleep quality and reduces nighttime awakenings [2].Passionflower (Maypop) acts as a natural sedative, with compounds that reduce nervous tension and support sleep onset [3].Chinese Skullcap, rich in baicalin, has a long history in traditional medicine for enhancing sleep quality [4].GABA 250 (Gamma-Aminobutyric Acid) is a primary inhibitory neurotransmitter that plays a vital role in calming brain activity and reducing neuronal excitability, helping to alleviate stress and shorten the time it takes to fall asleep. A randomized controlled trial demonstrated that 100 mg oral GABA significantly shortened sleep latency and increased non-REM sleep time [5].L-Theanine, an amino acid primarily found in green tea, promotes relaxation by increasing alpha brain wave activity, which correlates with calm focus and stress reduction. A clinical trial showed that L-Theanine intake improved sleep efficiency and reduced sleep disturbances [6].The Functional Brands Inc. Restorative Sleep Bundle by Kirkman is now available for purchase through Kirkman's website and practitionersFor more information, please visit www.kirkmangroup.com or call 1-800-245-8282. About Functional Brands Inc.Functional Brands Inc. is a trusted leader in high-quality wellness solutions, offering innovative products designed to support a wide range of health and fitness goals. Through a commitment to science-backed ingredients and holistic formulations, Functional Brands Inc. is dedicated to helping individuals improve their health, performance, and overall well-being.For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com.Kirkman® has been the leader in Ultratested® supplements since 1949, setting the gold standard in purity and hypoallergenic formulation. Our rigorous standards ensure that even the most sensitive communities-including those who cannot tolerate other supplements-can thrive from our formulations. With more than 70 years of clean science behind every product, Kirkman® is trusted by practitioners and patients worldwide for developing the cleanest, most precisely tested supplements available.Investor Relations Contact:
FunctionalBrands@icrinc.comReferences
[1] Cases, J., Ibarra, A., Feuillère, N., Roller, M., & Sukkar, S. (2011). Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism. https://pubmed.ncbi.nlm.nih.gov/22207903/[2] Zick, S. M., Wright, B. D., Sen, A., & Arnedt, J. T. (2011). Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study. BMC Complementary and Alternative Medicine. https://pubmed.ncbi.nlm.nih.gov/21939549/[3] Appel, K., Rose, T., Fiebich, B., Kammler, T., Hoffmann, C., & Weiss, G. (2011). Modulation of the ?-aminobutyric acid (GABA) system by Passiflora incarnata L. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/21089181/[4] Hui, K. M., Wang, X. H., & Xie, Y. (2000). The role of baicalin and other flavonoids in the sedative and anxiolytic effects of Scutellaria baicalensis. Phytomedicine.[5] Yamatsu, A., Yamashita, Y., Pandharipande, T., Maru, I., Kim, M., & Kimura, M. (2016). Effect of oral ?-aminobutyric acid (GABA) administration on sleep and its absorption in humans. Food Science and Biotechnology. https://pubmed.ncbi.nlm.nih.gov/30263304/[6] Kimura, K., Ozeki, M., Juneja, L. R., & Ohira, H. (2007). L-Theanine reduces psychological and physiological stress responses. Biological Psychology. https://pubmed.ncbi.nlm.nih.gov/16930802/To view the source version of this press release, please visit https://www.newsfilecorp.com/release/284077
Original: Functional Brands Inc. Introduces Kirkman's(R) Exciting New Restorative Sleep Bundle for Deep, Refreshing Sleep Without Grogginess

You guys see today? That massive drop 27%. Followed by the release of quarterly earnings... Profitable ones might I add! Hope nobody got scared. Don't miss it guys. This could be it. Seriously look at the numbers!!! News doesn't seem to be too quick on this site. That was all released at like 5:00 p.m. not 9:00...

You're clearly just one of these guys that comes on to every stock chat and says that his way of investing is the only way. Don't be dumb. Use it as your new mantra. Dbd you can say to be hip. This stock is so grossly oversold to a point that's unbelievable it's only a month old. Yes $8 is not what they are worth per share but do a couple estimates on value after hitting any number reasonable for the company... It's a direct listing... Have some sense when you say things. Simply think actually do research and then make your opinion stated or don't talk at all...

The clown says he only bought 35 grand of stock here. That’s right 35 grand lmao

lol. Sure

$MEHA: Grabbed a few at $0.35

Only 100k shares.
Hoping for a nice recovery here like what happened to $DTCK


GO $MEHA

$MEHA: Wow.... how much lower........ now $0.66

Opened this week at $7

Already sub $1

Going to the pennies........... maybe sub $0.10 ????

Gonna put a super lowball bid in to get it filled.

https://www.functionalbrandsinc.com/


GO $MEHA